Effect of Fluoxetine on the Hippocampus of Wistar Albino Rats in Cold Restraint Stress Model
Stress has been known to be a potential modulator of learning and memory. Long term stress can lead to depression. Fluoxetine is a selective serotonin reuptake inhibitor group of drug used in the treatment of depression. The present study was conducted to evaluate the potential of Fluoxetine on cold...
Saved in:
| Published in | Journal of clinical and diagnostic research Vol. 11; no. 6; pp. AF01 - AF06 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | English |
| Published |
India
JCDR Research and Publications Private Limited
01.06.2017
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 2249-782X 0973-709X |
| DOI | 10.7860/JCDR/2017/26958.9953 |
Cover
Loading…
| Abstract | Stress has been known to be a potential modulator of learning and memory. Long term stress can lead to depression. Fluoxetine is a selective serotonin reuptake inhibitor group of drug used in the treatment of depression.
The present study was conducted to evaluate the potential of Fluoxetine on cold restraint induced stress in the hippocampus of Wistar rats.
A total of 18 male wistar albino rats were divided randomly into three groups (n=6). Group 1 was the control group which were kept in normal laboratory conditions. Group 2 was the negative control group which were given cold restraint stress for period of four weeks. Group 3 was the experimental group, where the animals were pretreated with fluoxetine 10 mg/kg for a period of one week followed by cold restraint stress for 30 minutes and cotreated with fluoxetine 10 mg/kg for a period of four weeks. The whole study was done for a period of five weeks followed by behavioural studies and subsequently sacrificed with removal of brain for various histological, Immunohistochemical (IHC), neurochemical and antioxidant analysis. The values were expressed as Mean±SEM. One-way analysis of variance followed by Tukey's multiple comparisons test was used for the comparison of means. A probability of 0.05 and less was taken as statistically significant using Prism Graphpad software version 6.01.
The results show there was significant improvement in the Morris water maze test after treatment with fluoxetine in Group 2. Similar results were also noted in the levels of neurotransmitters and antioxidant levels in brain and also in the number of cells counted in IHC and histological studies by H&E when Group 3 was compared with Group 2. The treatment reversed the damage in Group 2 which was comparable with the control group.
The results revealed that administration of fluoxetine 10 mg/kg given orally has a potential antistressor effect by improving the neurogenic and neuroprotective effect on the cold restraint stress induced hippocampal damage. |
|---|---|
| AbstractList | Stress has been known to be a potential modulator of learning and memory. Long term stress can lead to depression. Fluoxetine is a selective serotonin reuptake inhibitor group of drug used in the treatment of depression.
The present study was conducted to evaluate the potential of Fluoxetine on cold restraint induced stress in the hippocampus of Wistar rats.
A total of 18 male wistar albino rats were divided randomly into three groups (n=6). Group 1 was the control group which were kept in normal laboratory conditions. Group 2 was the negative control group which were given cold restraint stress for period of four weeks. Group 3 was the experimental group, where the animals were pretreated with fluoxetine 10 mg/kg for a period of one week followed by cold restraint stress for 30 minutes and cotreated with fluoxetine 10 mg/kg for a period of four weeks. The whole study was done for a period of five weeks followed by behavioural studies and subsequently sacrificed with removal of brain for various histological, Immunohistochemical (IHC), neurochemical and antioxidant analysis. The values were expressed as Mean±SEM. One-way analysis of variance followed by Tukey's multiple comparisons test was used for the comparison of means. A probability of 0.05 and less was taken as statistically significant using Prism Graphpad software version 6.01.
The results show there was significant improvement in the Morris water maze test after treatment with fluoxetine in Group 2. Similar results were also noted in the levels of neurotransmitters and antioxidant levels in brain and also in the number of cells counted in IHC and histological studies by H&E when Group 3 was compared with Group 2. The treatment reversed the damage in Group 2 which was comparable with the control group.
The results revealed that administration of fluoxetine 10 mg/kg given orally has a potential antistressor effect by improving the neurogenic and neuroprotective effect on the cold restraint stress induced hippocampal damage. Introduction: Stress has been known to be a potential modulator of learning and memory. Long term stress can lead to depression. Fluoxetine is a selective serotonin reuptake inhibitor group of drug used in the treatment of depression. Aim: The present study was conducted to evaluate the potential of Fluoxetine on cold restraint induced stress in the hippocampus of Wistar rats. Materials and Methods: A total of 18 male wistar albino rats were divided randomly into three groups (n=6). Group 1 was the control group which were kept in normal laboratory conditions. Group 2 was the negative control group which were given cold restraint stress for period of four weeks. Group 3 was the experimental group, where the animals were pretreated with fluoxetine 10 mg/kg for a period of one week followed by cold restraint stress for 30 minutes and cotreated with fluoxetine 10 mg/kg for a period of four weeks. The whole study was done for a period of five weeks followed by behavioural studies and subsequently sacrificed with removal of brain for various histological, Immunohistochemical (IHC), neurochemical and antioxidant analysis. The values were expressed as Mean±SEM. One-way analysis of variance followed by Tukey’s multiple comparisons test was used for the comparison of means. A probability of 0.05 and less was taken as statistically significant using Prism Graphpad software version 6.01. Results: The results show there was significant improvement in the Morris water maze test after treatment with fluoxetine in Group 2. Similar results were also noted in the levels of neurotransmitters and antioxidant levels in brain and also in the number of cells counted in IHC and histological studies by H&E when Group 3 was compared with Group 2. The treatment reversed the damage in Group 2 which was comparable with the control group. Conclusion: The results revealed that administration of fluoxetine 10 mg/kg given orally has a potential antistressor effect by improving the neurogenic and neuroprotective effect on the cold restraint stress induced hippocampal damage. Stress has been known to be a potential modulator of learning and memory. Long term stress can lead to depression. Fluoxetine is a selective serotonin reuptake inhibitor group of drug used in the treatment of depression.INTRODUCTIONStress has been known to be a potential modulator of learning and memory. Long term stress can lead to depression. Fluoxetine is a selective serotonin reuptake inhibitor group of drug used in the treatment of depression.The present study was conducted to evaluate the potential of Fluoxetine on cold restraint induced stress in the hippocampus of Wistar rats.AIMThe present study was conducted to evaluate the potential of Fluoxetine on cold restraint induced stress in the hippocampus of Wistar rats.A total of 18 male wistar albino rats were divided randomly into three groups (n=6). Group 1 was the control group which were kept in normal laboratory conditions. Group 2 was the negative control group which were given cold restraint stress for period of four weeks. Group 3 was the experimental group, where the animals were pretreated with fluoxetine 10 mg/kg for a period of one week followed by cold restraint stress for 30 minutes and cotreated with fluoxetine 10 mg/kg for a period of four weeks. The whole study was done for a period of five weeks followed by behavioural studies and subsequently sacrificed with removal of brain for various histological, Immunohistochemical (IHC), neurochemical and antioxidant analysis. The values were expressed as Mean±SEM. One-way analysis of variance followed by Tukey's multiple comparisons test was used for the comparison of means. A probability of 0.05 and less was taken as statistically significant using Prism Graphpad software version 6.01.MATERIALS AND METHODSA total of 18 male wistar albino rats were divided randomly into three groups (n=6). Group 1 was the control group which were kept in normal laboratory conditions. Group 2 was the negative control group which were given cold restraint stress for period of four weeks. Group 3 was the experimental group, where the animals were pretreated with fluoxetine 10 mg/kg for a period of one week followed by cold restraint stress for 30 minutes and cotreated with fluoxetine 10 mg/kg for a period of four weeks. The whole study was done for a period of five weeks followed by behavioural studies and subsequently sacrificed with removal of brain for various histological, Immunohistochemical (IHC), neurochemical and antioxidant analysis. The values were expressed as Mean±SEM. One-way analysis of variance followed by Tukey's multiple comparisons test was used for the comparison of means. A probability of 0.05 and less was taken as statistically significant using Prism Graphpad software version 6.01.The results show there was significant improvement in the Morris water maze test after treatment with fluoxetine in Group 2. Similar results were also noted in the levels of neurotransmitters and antioxidant levels in brain and also in the number of cells counted in IHC and histological studies by H&E when Group 3 was compared with Group 2. The treatment reversed the damage in Group 2 which was comparable with the control group.RESULTSThe results show there was significant improvement in the Morris water maze test after treatment with fluoxetine in Group 2. Similar results were also noted in the levels of neurotransmitters and antioxidant levels in brain and also in the number of cells counted in IHC and histological studies by H&E when Group 3 was compared with Group 2. The treatment reversed the damage in Group 2 which was comparable with the control group.The results revealed that administration of fluoxetine 10 mg/kg given orally has a potential antistressor effect by improving the neurogenic and neuroprotective effect on the cold restraint stress induced hippocampal damage.CONCLUSIONThe results revealed that administration of fluoxetine 10 mg/kg given orally has a potential antistressor effect by improving the neurogenic and neuroprotective effect on the cold restraint stress induced hippocampal damage. |
| Author | Jayakumar, Saikarthik |
| Author_xml | – sequence: 1 givenname: Saikarthik surname: Jayakumar fullname: Jayakumar, Saikarthik |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28764145$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kU1v1DAYhC1URLeFf4CQj1zStR1_hVu1tLSoCGmhag9IlmO_AVfZONiO1P57km7LgQMnS9YzY8_METoY4gAIvaXkRGlJ1p83H7drRqhaM9kIfdI0on6BVqRRdaVIc3uAVozxplKa3R6io5zvCJFS1vIVOmRaSU65WKEfZ10HruDY4fN-ivdQwgA4Drj8AnwRxjE6uxunvAA3IReb8GnfhiHirS0ZhwFvYu_xFnJJNgwFfysJcsZfoof-NXrZ2T7Dm6fzGF2fn33fXFRXXz9dbk6vKsdpUypVt1LVjRdScernMFI5281fhdYzaKWnvuZaOFXb2jvBuONetN457R1htKuP0eXe10d7Z8YUdjY9mGiDebyI6aexqQTXg5FEy1bP8ZUWXHdgLW07mJvRVBPpYfZ6v_caU_w9zbHMLmQHfW8HiFM2tGFCUKGYnNF3T-jU7sD_ffi53Rn4sAdcijkn6IwLxZYQh6Ws3lBilinNMqVZpjSPU5plylnM_xE_-_9X9gesy6D3 |
| CitedBy_id | crossref_primary_10_2174_0929866530666230419093531 crossref_primary_10_1186_s43088_024_00482_0 crossref_primary_10_2174_1389557521666210415112601 crossref_primary_10_1080_10253890_2019_1660316 crossref_primary_10_15446_rcciquifa_v52n3_111080 |
| ContentType | Journal Article |
| DBID | AAYXX CITATION NPM 7X8 DOA |
| DOI | 10.7860/JCDR/2017/26958.9953 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 0973-709X |
| EndPage | AF06 |
| ExternalDocumentID | oai_doaj_org_article_6086b887678548feaa1bfe00681806de 28764145 10_7860_JCDR_2017_26958_9953 |
| Genre | Journal Article |
| GroupedDBID | --- 2WC 5VS AAYXX ABDBF ACUHS ADBBV ALMA_UNASSIGNED_HOLDINGS BAWUL BCNDV CITATION DIK E3Z EBD EOJEC ESX GROUPED_DOAJ GX1 HYE KQ8 M~E OBODZ OK1 P6G RNS RPM TR2 TUS ~8M NPM 7X8 |
| ID | FETCH-LOGICAL-c419t-73b6739d56741d69567caf663ebd2eb6d1d3485c73a3dc524c4d5bdcc8dc021f3 |
| IEDL.DBID | DOA |
| ISSN | 2249-782X |
| IngestDate | Wed Aug 27 00:51:59 EDT 2025 Fri Jul 11 07:07:43 EDT 2025 Thu Jan 02 22:42:27 EST 2025 Tue Jul 01 01:23:34 EDT 2025 Thu Apr 24 23:00:18 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Neuroprotective Neurogenesis Water maze |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c419t-73b6739d56741d69567caf663ebd2eb6d1d3485c73a3dc524c4d5bdcc8dc021f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://doaj.org/article/6086b887678548feaa1bfe00681806de |
| PMID | 28764145 |
| PQID | 1925515726 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_6086b887678548feaa1bfe00681806de proquest_miscellaneous_1925515726 pubmed_primary_28764145 crossref_citationtrail_10_7860_JCDR_2017_26958_9953 crossref_primary_10_7860_JCDR_2017_26958_9953 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2017-06-01 |
| PublicationDateYYYYMMDD | 2017-06-01 |
| PublicationDate_xml | – month: 06 year: 2017 text: 2017-06-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | India |
| PublicationPlace_xml | – name: India |
| PublicationTitle | Journal of clinical and diagnostic research |
| PublicationTitleAlternate | J Clin Diagn Res |
| PublicationYear | 2017 |
| Publisher | JCDR Research and Publications Private Limited |
| Publisher_xml | – name: JCDR Research and Publications Private Limited |
| References | 1960381 - Int Clin Psychopharmacol. 1991 Summer;6(2):117-24 19066539 - J Vis Exp. 2008 Sep 24;(19):null 7472505 - J Neurosci. 1995 Nov;15(11):7539-47 4556490 - Anal Biochem. 1972 Jun;47(2):389-94 27496030 - Bull Exp Biol Med. 2016 Jul;161(3):351-4 10844239 - Anim Reprod Sci. 2000 Jul 2;60-61:743-52 28100752 - J Neurosci. 2017 Jan 18;37(3):726-737 9822768 - J Neurosci. 1998 Dec 1;18(23):10150-6 24300695 - Neurosci Biobehav Rev. 2014 Jan;38:173-92 7857640 - Neuron. 1995 Feb;14(2):303-15 21385396 - Mol Brain. 2011 Mar 08;4:10 8140464 - Soc Sci Med. 1994 Jan;38(2):373-81 17716101 - Annu Rev Clin Psychol. 2005;1:607-28 27754387 - Molecules. 2016 Oct 13;21(10 ) 4823943 - J Nutr. 1974 May;104(5):580-7 10958110 - Psychopharmacology (Berl). 2000 Jul;151(1):7-12 14749091 - Psychoneuroendocrinology. 2004 May;29(4):423-47 2690106 - Prog Clin Biol Res. 1989;317:333-51 24281320 - Mamm Genome. 2014 Feb;25(1-2):49-74 26408987 - Neuroscience. 2015 Dec 3;310:561-77 8601816 - J Neurosci. 1996 Apr 1;16(7):2365-72 2452945 - Life Sci. 1988;42(19):1847-53 9046559 - Annu Rev Psychol. 1997;48:191-214 10180753 - Pharmacoeconomics. 1998 May;13(5 Pt 1):543-61 7825902 - Ann N Y Acad Sci. 1994 Nov 30;746:411-4 6490072 - Indian J Biochem Biophys. 1984 Apr;21(2):130-2 15474655 - Behav Brain Res. 2005 Jan 6;156(1):105-14 17716090 - Annu Rev Clin Psychol. 2005;1:293-319 12122314 - Behav Pharmacol. 2002 May;13(3):237-42 7897207 - J Immunol. 1995 Apr 1;154(7):3194-203 1375306 - Life Sci. 1992;50(22):1683-90 21175261 - J Neurotrauma. 2011 Feb;28(2):259-68 10818138 - J Neurosci. 2000 Jun 1;20(11):4030-6 9755354 - Biol Psychiatry. 1998 Sep 1;44(5):324-35 23780498 - Drug Res (Stuttg). 2013 Oct;63(10 ):532-9 22429479 - Psychiatry Res. 2012 Aug 15;198(3):407-11 11063970 - Biol Psychiatry. 2000 Oct 15;48(8):732-9 10471245 - Harv Rev Psychiatry. 1999 Jul-Aug;7(2):69-84 28012396 - Biomed Pharmacother. 2017 Feb;86:414-425 23557208 - J Neurotrauma. 2013 Sep 1;30(17 ):1521-30 2522809 - Brain Res. 1989 Jan 16;477(1-2):300-7 21624059 - Basic Clin Pharmacol Toxicol. 2011 Nov;109(5):365-71 10617146 - J Neurochem. 2000 Jan;74(1):406-13 11919662 - Psychopharmacology (Berl). 2002 Apr;160(4):353-61 11331918 - Nat Rev Neurosci. 2001 May;2(5):343-51 11850470 - J Neurosci. 2002 Feb 15;22(4):1436-42 |
| References_xml | – reference: 7897207 - J Immunol. 1995 Apr 1;154(7):3194-203 – reference: 14749091 - Psychoneuroendocrinology. 2004 May;29(4):423-47 – reference: 7472505 - J Neurosci. 1995 Nov;15(11):7539-47 – reference: 1960381 - Int Clin Psychopharmacol. 1991 Summer;6(2):117-24 – reference: 19066539 - J Vis Exp. 2008 Sep 24;(19):null – reference: 21624059 - Basic Clin Pharmacol Toxicol. 2011 Nov;109(5):365-71 – reference: 2522809 - Brain Res. 1989 Jan 16;477(1-2):300-7 – reference: 1375306 - Life Sci. 1992;50(22):1683-90 – reference: 15474655 - Behav Brain Res. 2005 Jan 6;156(1):105-14 – reference: 22429479 - Psychiatry Res. 2012 Aug 15;198(3):407-11 – reference: 11331918 - Nat Rev Neurosci. 2001 May;2(5):343-51 – reference: 2690106 - Prog Clin Biol Res. 1989;317:333-51 – reference: 10180753 - Pharmacoeconomics. 1998 May;13(5 Pt 1):543-61 – reference: 17716101 - Annu Rev Clin Psychol. 2005;1:607-28 – reference: 12122314 - Behav Pharmacol. 2002 May;13(3):237-42 – reference: 8601816 - J Neurosci. 1996 Apr 1;16(7):2365-72 – reference: 23557208 - J Neurotrauma. 2013 Sep 1;30(17 ):1521-30 – reference: 23780498 - Drug Res (Stuttg). 2013 Oct;63(10 ):532-9 – reference: 10818138 - J Neurosci. 2000 Jun 1;20(11):4030-6 – reference: 21175261 - J Neurotrauma. 2011 Feb;28(2):259-68 – reference: 4556490 - Anal Biochem. 1972 Jun;47(2):389-94 – reference: 21385396 - Mol Brain. 2011 Mar 08;4:10 – reference: 7825902 - Ann N Y Acad Sci. 1994 Nov 30;746:411-4 – reference: 10958110 - Psychopharmacology (Berl). 2000 Jul;151(1):7-12 – reference: 11919662 - Psychopharmacology (Berl). 2002 Apr;160(4):353-61 – reference: 10844239 - Anim Reprod Sci. 2000 Jul 2;60-61:743-52 – reference: 27754387 - Molecules. 2016 Oct 13;21(10 ): – reference: 27496030 - Bull Exp Biol Med. 2016 Jul;161(3):351-4 – reference: 28100752 - J Neurosci. 2017 Jan 18;37(3):726-737 – reference: 2452945 - Life Sci. 1988;42(19):1847-53 – reference: 24281320 - Mamm Genome. 2014 Feb;25(1-2):49-74 – reference: 9046559 - Annu Rev Psychol. 1997;48:191-214 – reference: 26408987 - Neuroscience. 2015 Dec 3;310:561-77 – reference: 8140464 - Soc Sci Med. 1994 Jan;38(2):373-81 – reference: 9822768 - J Neurosci. 1998 Dec 1;18(23):10150-6 – reference: 9755354 - Biol Psychiatry. 1998 Sep 1;44(5):324-35 – reference: 11063970 - Biol Psychiatry. 2000 Oct 15;48(8):732-9 – reference: 11850470 - J Neurosci. 2002 Feb 15;22(4):1436-42 – reference: 6490072 - Indian J Biochem Biophys. 1984 Apr;21(2):130-2 – reference: 28012396 - Biomed Pharmacother. 2017 Feb;86:414-425 – reference: 24300695 - Neurosci Biobehav Rev. 2014 Jan;38:173-92 – reference: 10617146 - J Neurochem. 2000 Jan;74(1):406-13 – reference: 10471245 - Harv Rev Psychiatry. 1999 Jul-Aug;7(2):69-84 – reference: 4823943 - J Nutr. 1974 May;104(5):580-7 – reference: 7857640 - Neuron. 1995 Feb;14(2):303-15 – reference: 17716090 - Annu Rev Clin Psychol. 2005;1:293-319 |
| SSID | ssj0066636 |
| Score | 2.13329 |
| Snippet | Stress has been known to be a potential modulator of learning and memory. Long term stress can lead to depression. Fluoxetine is a selective serotonin reuptake... Introduction: Stress has been known to be a potential modulator of learning and memory. Long term stress can lead to depression. Fluoxetine is a selective... |
| SourceID | doaj proquest pubmed crossref |
| SourceType | Open Website Aggregation Database Index Database Enrichment Source |
| StartPage | AF01 |
| SubjectTerms | neurogenesis neuroprotective water maze |
| Title | Effect of Fluoxetine on the Hippocampus of Wistar Albino Rats in Cold Restraint Stress Model |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/28764145 https://www.proquest.com/docview/1925515726 https://doaj.org/article/6086b887678548feaa1bfe00681806de |
| Volume | 11 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LixQxEA6yB_Eirs9xdYngNU6n8-o-ruOOw8J6GF2cgxDyhIW2e9jpAX--laRn0IPsxUsfmoROf6nk-4qkqhB6L2MQTrQ18cDFhNPKE8MrSyivlamr6Fi-8n_9Ra5u-NVGbP4o9ZXuhJX0wAW4uQTNbWElwKYK4joGY6iNIUU20KaSPqTdFzjv4EyVPRg0eS4OCPzUEuDATQmaU42s5leLT2tw-ama17IVzYe2FewvUsq5-_8tODPxLJ-gx5NixBdlpKfoQeifoofX05n4M_SjJCDGQ8TLbj_8SjHMAQ89BmmHV7fbLbDVz-1-lxp8T2rxDl904A8PeG3GHb7t8WLoPF6HXS4XMeKvOXwEpypp3XN0s7z8tliRqWYCcZy2I1HMSsVaLyRIBQ8_KJUzEeAI1tfBSk89441wihnmnai5415Y71zjHdB9ZC_QST_04RXCLcAaQ1S8ipJ7yi309ilwHiSuMyrOEDuApt2UUDwNtNPgWCSodYJaJ6h1hlonqGeIHHttS0KNe9p_TPNxbJvSYecXYCR6MhJ9n5HM0LvDbGpYPulMxPRh2O80CFzQjELVcoZelmk-fgqcSckpF6__xxDO0KP0Z-WW2Rt0Mt7tw1vQM6M9z6YLz88b-htwau0k |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+Fluoxetine+on+the+Hippocampus+of+Wistar+Albino+Rats+in+Cold+Restraint+Stress+Model&rft.jtitle=Journal+of+clinical+and+diagnostic+research&rft.au=Saikarthik+Jayakumar&rft.au=Gunapriya+Raghunath&rft.au=Saraswathi+Ilango&rft.au=J+Vijayakumar&rft.date=2017-06-01&rft.pub=JCDR+Research+and+Publications+Private+Limited&rft.issn=2249-782X&rft.eissn=0973-709X&rft.volume=11&rft.issue=6&rft.spage=AF01&rft.epage=AF06&rft_id=info:doi/10.7860%2FJCDR%2F2017%2F26958.9953&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_6086b887678548feaa1bfe00681806de |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2249-782X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2249-782X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2249-782X&client=summon |